News Prothena Corporation plc

Equities

PRTA

IE00B91XRN20

Real-time Estimate Cboe BZX Other stock markets 11:18:03 2024-05-23 am EDT			5-day change	1st Jan Change
20.66 ^USD	-4.31%		-11.29%	-42.90%

May. 09	RBC Cuts Price Target on Prothena to $28 From $35, Keeps Sector Perform, Speculative Risk	MT
May. 08	Earnings Flash (PRTA) PROTHENA CORPORATION Posts Q1 Revenue $50,000	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RBC Cuts Price Target on Prothena to $28 From $35, Keeps Sector Perform, Speculative Risk	May. 09	MT
Prothena: Q1 Earnings Snapshot	May. 08	AQ
Prothena : Corporate Overview	May. 08	PU
Earnings Flash (PRTA) PROTHENA CORPORATION Posts Q1 Revenue $50,000	May. 08	MT
Prothena Reports First Quarter 2024 Financial Results and Business Highlights	May. 08	BU
Prothena Corporation plc Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 08	CI
Prothena to Report First Quarter 2024 Financial Results on May 8	May. 01	BU
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia and Lymphoma	Apr. 16	AQ
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma	Apr. 15	BU
Prothena : Director's Report and Financial Statements for Fiscal Year 2023	Mar. 29	PU
Prothena to Participate in Upcoming Healthcare Conferences	Mar. 05	BU
Prothena Names David Ford as Chief People Officer	Mar. 04	MT
Prothena Appoints David Ford to Newly Created Chief People Officer Position	Mar. 04	BU
Prothena Appoints David Ford to Newly Created Chief People Officer	Mar. 04	CI
Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate	Feb. 21	BU
Prothena Corporation plc Announces Board Changes	Feb. 21	CI
Oppenheimer Cuts Prothena Price Target to $80 From $98, Maintains Outperform Rating	Feb. 20	MT
Sector Update: Health Care Stocks Gain Pre-Bell Friday	Feb. 16	MT
RBC Trims Price Target on Prothena to $35 From $36, Keeps Sector Perform, Speculative Risk	Feb. 16	MT
Prothena Posts Q4 Net Loss as Revenue Slumps	Feb. 15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Prothena Corporation plc

Equities

PRTA

IE00B91XRN20

Summary

Filters